“Price dualization for cervical cancer vaccines will be fully reviewed”

While cervical cancer vaccines will be included in the National Immunization Program(NIP) from the coming June, the Korea Centers for Disease Control and Prevention(KCDC) was known to consider the dualization of MSD’s ‘Gardasil’ and GSK’s ‘Cervarix’ prices.

On the 15^th, the KCDC announced it will finally select targets for the NIP through having a Vaccination Expert Committee within this week ...